TransMedics Total Assets vs Current Deferred Revenue Analysis

TMDX Stock  USD 87.11  6.50  8.06%   
TransMedics financial indicator trend analysis is much more than just breaking down TransMedics Group prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether TransMedics Group is a good investment. Please check the relationship between TransMedics Total Assets and its Current Deferred Revenue accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TransMedics Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

Total Assets vs Current Deferred Revenue

Total Assets vs Current Deferred Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of TransMedics Group Total Assets account and Current Deferred Revenue. At this time, the significance of the direction appears to have almost identical trend.
The correlation between TransMedics' Total Assets and Current Deferred Revenue is 0.96. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of TransMedics Group, assuming nothing else is changed. The correlation between historical values of TransMedics' Total Assets and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of TransMedics Group are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Total Assets i.e., TransMedics' Total Assets and Current Deferred Revenue go up and down completely randomly.

Correlation Coefficient

0.96
Relationship DirectionPositive 
Relationship StrengthVery Strong

Total Assets

Total assets refers to the total amount of TransMedics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in TransMedics Group books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.
Most indicators from TransMedics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into TransMedics Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TransMedics Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
At this time, TransMedics' Selling General Administrative is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 0.96 in 2024, despite the fact that Tax Provision is likely to grow to (1.4 M).
 2021 2022 2023 2024 (projected)
Total Operating Expenses60.6M96.7M182.8M192.0M
Research Development22.3M26.8M36.1M22.2M

TransMedics fundamental ratios Correlations

0.980.7-0.090.81-0.750.860.99-0.120.98-0.370.990.941.00.610.910.960.990.72-0.090.980.980.960.640.98-0.09
0.980.7-0.160.8-0.80.920.96-0.060.97-0.370.990.950.980.640.930.980.980.73-0.040.970.970.940.650.97-0.03
0.70.7-0.120.93-0.740.470.690.060.59-0.080.730.530.730.960.830.820.70.87-0.240.60.580.520.160.580.01
-0.09-0.16-0.120.00.12-0.36-0.08-0.44-0.170.17-0.14-0.2-0.07-0.090.01-0.15-0.110.240.35-0.16-0.13-0.14-0.34-0.14-0.35
0.810.80.930.0-0.750.580.79-0.270.71-0.050.820.660.850.860.890.870.810.84-0.20.720.710.650.270.71-0.3
-0.75-0.8-0.740.12-0.75-0.69-0.720.01-0.660.01-0.81-0.66-0.78-0.79-0.82-0.82-0.73-0.790.01-0.66-0.65-0.6-0.27-0.650.02
0.860.920.47-0.360.58-0.690.82-0.020.9-0.320.880.870.840.440.750.840.850.48-0.150.90.890.880.750.890.02
0.990.960.69-0.080.79-0.720.82-0.080.96-0.50.980.930.980.590.930.941.00.71-0.070.960.960.940.560.96-0.04
-0.12-0.060.06-0.44-0.270.01-0.02-0.08-0.05-0.31-0.06-0.07-0.140.1-0.1-0.02-0.080.0-0.04-0.05-0.08-0.040.06-0.070.98
0.980.970.59-0.170.71-0.660.90.96-0.05-0.420.970.970.960.490.830.920.970.62-0.071.01.01.00.771.0-0.01
-0.37-0.37-0.080.17-0.050.01-0.32-0.5-0.31-0.42-0.36-0.46-0.340.02-0.39-0.32-0.45-0.12-0.16-0.42-0.44-0.44-0.14-0.44-0.43
0.990.990.73-0.140.82-0.810.880.98-0.060.97-0.360.950.990.660.930.980.980.75-0.050.970.970.940.620.97-0.03
0.940.950.53-0.20.66-0.660.870.93-0.070.97-0.460.950.920.450.810.910.940.590.120.970.970.970.740.97-0.03
1.00.980.73-0.070.85-0.780.840.98-0.140.96-0.340.990.920.650.930.960.990.75-0.10.960.960.930.590.96-0.12
0.610.640.96-0.090.86-0.790.440.590.10.490.020.660.450.650.770.760.60.9-0.180.50.480.420.080.480.05
0.910.930.830.010.89-0.820.750.93-0.10.83-0.390.930.810.930.770.950.920.870.010.840.850.790.330.84-0.06
0.960.980.82-0.150.87-0.820.840.94-0.020.92-0.320.980.910.960.760.950.950.830.00.930.920.890.570.920.0
0.990.980.7-0.110.81-0.730.851.0-0.080.97-0.450.980.940.990.60.920.950.71-0.10.980.980.950.610.97-0.05
0.720.730.870.240.84-0.790.480.710.00.62-0.120.750.590.750.90.870.830.710.090.630.620.570.150.620.02
-0.09-0.04-0.240.35-0.20.01-0.15-0.07-0.04-0.07-0.16-0.050.12-0.1-0.180.010.0-0.10.09-0.07-0.05-0.04-0.09-0.050.05
0.980.970.6-0.160.72-0.660.90.96-0.051.0-0.420.970.970.960.50.840.930.980.63-0.071.00.990.761.0-0.01
0.980.970.58-0.130.71-0.650.890.96-0.081.0-0.440.970.970.960.480.850.920.980.62-0.051.00.990.751.0-0.03
0.960.940.52-0.140.65-0.60.880.94-0.041.0-0.440.940.970.930.420.790.890.950.57-0.040.990.990.81.00.01
0.640.650.16-0.340.27-0.270.750.560.060.77-0.140.620.740.590.080.330.570.610.15-0.090.760.750.80.760.06
0.980.970.58-0.140.71-0.650.890.96-0.071.0-0.440.970.970.960.480.840.920.970.62-0.051.01.01.00.76-0.02
-0.09-0.030.01-0.35-0.30.020.02-0.040.98-0.01-0.43-0.03-0.03-0.120.05-0.060.0-0.050.020.05-0.01-0.030.010.06-0.02
Click cells to compare fundamentals

TransMedics Account Relationship Matchups

TransMedics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets105.3M152.0M134.9M277.1M706.0M741.3M
Total Current Liabilities16.1M11.9M23.2M23.7M54.9M57.7M
Total Stockholder Equity54.6M103.9M67.9M187.4M137.2M144.1M
Other Liab1.1M759K389K1.6M1.4M901.6K
Net Tangible Assets54.6M103.9M67.9M187.4M215.5M226.3M
Retained Earnings(369.5M)(398.2M)(442.4M)(478.7M)(503.7M)(528.9M)
Accounts Payable7.2M1.2M6.7M3.3M12.7M13.4M
Cash20.1M24.6M25.6M201.2M394.8M414.6M
Long Term Debt34.1M34.7M35.2M58.7M506.2M531.5M
Inventory11.2M11.9M14.9M20.6M44.2M46.4M
Total Liab50.7M48.1M67.0M89.8M568.8M597.3M
Total Current Assets100.0M146.8M118.7M252.3M510.7M536.2M
Common Stock424.1M502.2M510.5M666.3M641.1M375.9M
Property Plant Equipment4.8M4.8M15.7M24.4M28.0M29.4M
Other Current Liab8.7M10.4M16.3M17.2M36.2M38.0M
Net Receivables6.6M6.9M5.9M27.6M63.6M66.8M
Common Stock Shares Outstanding14.2M24.7M27.6M29.6M32.5M24.3M
Other Stockholder Equity(105.3M)(95K)68.0M(225K)(202.5K)(192.4K)
Short Long Term Debt Total34.1M34.7M43.8M67.6M515.9M541.7M
Property Plant And Equipment Net4.8M4.8M15.7M24.4M180.5M189.5M
Current Deferred Revenue166K263K250K241K2.0M2.1M
Net Debt14.1M10.1M(17.0M)(133.6M)121.1M127.2M
Non Current Assets Total5.3M5.3M16.2M24.9M195.4M205.2M
Cash And Short Term Investments80.7M125.6M92.5M201.2M394.8M414.6M
Common Stock Total Equity331.2M424.1M502.2M510.5M587.1M389.0M
Long Term Debt Total33.7M34.1M34.7M35.2M40.5M31.8M
Liabilities And Stockholders Equity105.3M152.0M134.9M277.1M706.0M741.3M
Non Current Liabilities Total34.5M36.3M43.8M66.1M513.9M539.6M
Other Current Assets1.5M4.7M5.5M2.9M8.0M8.4M
Net Invested Capital88.8M138.5M103.1M246.1M643.4M675.6M
Property Plant And Equipment Gross4.8M4.8M15.7M24.4M201.8M211.9M
Accumulated Other Comprehensive Income(2K)(95K)(188K)(225K)(199K)(209.0K)
Net Working Capital83.9M134.9M95.5M228.6M455.7M478.5M
Capital Stock424.1M502.2M510.5M666.3M641.1M563.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for TransMedics Stock Analysis

When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.